Unboosted Atazanavir as Initial ART Therapy in China

This study has been completed.
Sponsor:
Collaborator:
BMS company
Information provided by (Responsible Party):
NCAIDS, National Center for AIDS/STD Control and Prevention, China CDC
ClinicalTrials.gov Identifier:
NCT01459575
First received: October 24, 2011
Last updated: NA
Last verified: October 2011
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2006
  Primary Completion Date: December 2005 (Final data collection date for primary outcome measure)